Our news
- 18/07/2019: Pharegis implemented optimized procedures for state registration of pharmaceuticals in Eurasian Economic Union.
- 20/06/2019: Pharegis updated timelines and practical approaches for Russian and EEU GMP inspection applications and procedures.
- 03/04/2019: Renewed general monographs of Russian state pharmacopeia XIV ed. have been analyzed.
Global industry news
Feed not found.
Contact us
Activities
Regulatory Events Russia
Russian Regulatory News
Pharegis LLC / ООО "Фареджис"
-
- Business address:
3-1 Begovaya str. ("NordStar Tower", 31st fl.), Moscow, Russia 125284
Legal & postal address:
11A-11 Cherkizovskaya B. str., Moscow, Russia 107392
D-U-N-S: 362071645
-
- + 7 985 908 58 18 9am-6pm GMT+3
-
- http://www.pharegis.com
Regulatory news
Drugs.com - New Drug Approvals
- FDA Approves Jesduvroq (daprodustat) for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis
- FDA Approves Orserdu (elacestrant) for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
- FDA Approves Jaypirca (pirtobrutinib) for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma
- FDA Approves Brenzavvy (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes
- Brukinsa (zanubrutinib) Approved in the U.S. for Chronic Lymphocytic Leukemia
News and press releases
- Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU, , 31/01/2023
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 January 2023, CHMP, 27/01/2023
- EMA Committee for Advanced Therapies elects Ilona Reischl as its new Chair, CAT, 26/01/2023
- EMA update on shortages of antibiotics in the EU, , 26/01/2023
Drugs.com - Clinical Trials
- New Publication Validates SeptiCyte RAPID as a Triaging Tool for COVID-19 Patients SEATTLE and BRISBANE,...
- Ionis announces GSK has advanced bepirovirsen into Phase 3 development CARLSBAD, Calif., Feb. 1,...
- Aptose Initiates Dosing of Tuspetinib in APTIVATE Expansion Trial in Patients with Acute Myeloid Leukemia SAN DIEGO and TORONTO, Jan....
- Marburg Vaccine Shows Promising Results in First-in-Human Study January 30, 2023 -- A newly...
PharmaTimes: PharmaTimes Website RSS
- Endevica Bio and Orbit Discovery unite to boost cachexia therapeutics
- Bill & Melinda Gates Foundation funding for MIP Discovery
- BaseCure collaborates with Aptamer Group to boost gene therapies
- Vital NICE nod for Jazz’s Epidyolex
- Sanofi’s efanesoctocog alfa may be game-changer for haemophilia A patients